Diabetic Meds Flashcards

1
Q

Metformin

A

decreases gluconeogenesis and increasing peripheral utilisation of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dapagliflozin

A

SGLT2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Empagliflozin

A

SGLT2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SGLT2 inhibitor action

A

Reversibly inhibits sodium-glucose co-transporter 2 in the renal proximal convoluted tubule and ↑urinary glucose excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SGLT2 inhibitor S/E

A

UTI, DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SGLT2 inhibitor indication

A

Preferred if heart failure or renal disease are predominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Exenatide

A

GLP-1 receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Liraglutide

A

GLP-1 receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dulaglutide

A

GLP-1 receptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GLP-1 receptor agonist indication

A

preferred if cerebrovascular disease is predominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GLP-1 receptor agonist action

A

Bind to and activate the GLP-1 receptor to increase insulin secretion in the presence of raised glucose concentrations, suppress glycogen secretion and slow gastric emptying.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GLP-1 receptor agonist S/E

A

GI upset, Acute pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vildagliptin

A

DPP-4 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sitagliptin

A

DPP-4 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Saxagliptin

A

DPP-4 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DPP-4 inhibitor action

A

Increased levels of GLP-1 and GIP result in increased insulin synthesis and secretion from beta-cells and possibly reduced appetite